Skip to main content
Premium Trial:

Request an Annual Quote

Coda Genomics Closes $1.6M in Series B Funding

NEW YORK, Feb. 28 (GenomeWeb News) - Coda Genomics said today that it has secured $1.6 million in a Series B funding round.


The round was led by the Life Science Angels and includes venture capital firm Monitor Ventures and previous investors from the Tech Coast Angels. The round has two representatives on the Coda board of directors: Ken Kelley from the Life Science Angels, and Neal Bhadkamkar from Monitor Ventures.


Coda offers gene kits and services optimized to assemble DNA into single genes that the company said "are guaranteed to express specific proteins." The genes are optimized for correct self assembly, and also for characteristics that guarantee they express the desired protein at high levels in a biological expression system of choice, Coda said.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.